Subedi et al. (2017) investigated the levels of brain-derived neurotrophic factor (BDNF) in infants diagnosed with NAS due to opioid exposure and those who did not develop NAS after opioid exposure. This evidence concerns the gene BDNF and neonatal abstinence syndrome.